Your browser doesn't support javascript.
loading
Current Status of Dyslipidemia Treatment for Stroke Prevention.
Aradine, Elizabeth; Hou, Yan; Cronin, Carolyn A; Chaturvedi, Seemant.
Afiliación
  • Aradine E; Stroke Division and Department of Neurology, University of Maryland School of Medicine, 110 S. Paca St., Baltimore, MD, 21201, USA.
  • Hou Y; Stroke Division and Department of Neurology, University of Maryland School of Medicine, 110 S. Paca St., Baltimore, MD, 21201, USA.
  • Cronin CA; Stroke Division and Department of Neurology, University of Maryland School of Medicine, 110 S. Paca St., Baltimore, MD, 21201, USA.
  • Chaturvedi S; Stroke Division and Department of Neurology, University of Maryland School of Medicine, 110 S. Paca St., Baltimore, MD, 21201, USA. Schaturvedi@som.umaryland.edu.
Curr Neurol Neurosci Rep ; 20(8): 31, 2020 06 22.
Article en En | MEDLINE | ID: mdl-32572590
ABSTRACT
PURPOSE OF REVIEW Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. RECENT

FINDINGS:

However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin-kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Accidente Cerebrovascular / Dislipidemias / Anticolesterolemiantes Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Neurol Neurosci Rep Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Accidente Cerebrovascular / Dislipidemias / Anticolesterolemiantes Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Neurol Neurosci Rep Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos